APÉNDICE

Eritropoyetina^b (U/L)

4–27

12–25

8–67

14–222

7, 10, 47

Ferritina^b (ng/ml)

10–150^d

6–130

2–230

0–116

7, 10, 39, 42, 45, 47, 62, 70

Folato, eritrocítico (ng/ml)

150–450

137–589

94–828

109–663

45, 46, 72

Folato sérico (ng/ml)

5.4–18.0

2.6–15.0

0.8–24.0

1.4–20.7

7, 43, 45, 46, 53, 58, 72

Haptoglobina (mg/ml)

25–250

130 ± 43

115 ± 50

135 ± 65

26A

Hemoglobina^b (g/100 ml)

12–15.8^d

11.6–13.9

9.7–14.8

9.5–15.0

10, 45, 47, 58, 62

Hematócrito^b (%)

35.4–44.4

31.0–41.0

30.0–39.0

28.0–40.0

6, 7, 10, 42, 45 58, 66

Hierro, capacidad total de fijación (TIBC)^b (µg/100 ml)

251–406

278–403

No comunicado

359–609

62

Hierro sérico^b (µg/100 ml)

41–141

72–143

44–178

30–193

10, 62

Hemoglobina corpuscular media (MCH) (pg/células)

27–32

30–32

30–33

29–32

42

Volumen corpuscular medio (MCV) (×m³)

79–93

81–96

82–97

81–99

6, 42, 45, 58

Plaquetas (×10⁹/L)

165–415

174–391

155–409

146–429

4, 6, 16, 42, 45

Volumen plaquetario medio (MPV) (µm³)

6.4–11.0

7.7–10.3

7.8–10.2

8.2–10.4

42

Recuento de eritrocitos (RBC) (×10⁶/mm³)

4.00–5.20^d

3.42–4.55

2.81–4.49

2.71–4.43

6, 42, 45, 58

Amplitud de la distribución del volumen eritrocítico (RDW) (%)

<14.5

12.5–14.1

13.4–13.6

12.7–15.3

42

Recuento leucocítico (WBC) (×10³/mm³)

3.5–9.1

5.7–13.6

5.6–14.8

5.9–16.9

6, 9, 42, 45, 58

Neutrófilos (×10³/mm³)

1.4–4.6

3.6–10.1

3.8–12.3

3.9–13.1

4, 6, 9, 42

Linfocitos (×10³/mm³)

0.7–4.6

1.1–3.6

0.9–3.9

1.0–3.6

4, 6, 9, 42

Monocitos (×10³/mm³)

0.1–0.7

0.1–1.1

0.1–1.1

0.1–1.4

6, 9, 42

Eosinófilos (×10³/mm³)

0–0.6

0–0.6

0–0.6

0–0.6

6, 9

Basófilos (×10³/mm³)

0–0.2

0–0.1

0–0.1

0–0.1

6, 9

Transferrina (mg/100 ml)

200–400^c

254–344

220–441

288–530

39, 42

Transferrina, saturación sin hierro (%)

22–46^b

No comunicado

10–44

5–37

47

Transferrina, saturación con hierro (%)

22–46^b

No comunicado

18–92

9–98

47

COAGULACIÓN

Adultas no embarazadas^a

Primer trimestre

Segundo trimestre

Tercer trimestre

Referencias

Activador del plasminógeno hístico (ng/ml)

1.6–13^h

1.8–6.0

2.36–6.6

3.34–9.20

15, 16, 25C

Antitrombina III, funcional (%)

70–130

89–114

78–126

82–116

15, 16, 39A

Dímero-D (µg/ml)

0.22–0.74

0.05–0.95

0.32–1.29

0.13–1.7

16, 25, 25C, 35, 39A, 41A, 51

Enfermedad de von Willebrand

Antígeno de factor de von Willebrand (%)

75–125

62–318

90–247

84–422

39A, 44A, 73

ADAMTS-13, proteasa desdobladora de von Willebrand (%)

40–170ⁱ

40–160

22–135

38–105

39A, 44A

Factor V (%)

50–150

75–95

72–96

60–88

40

Factor VII (%)

50–150

100–146

95–153

149–2 110

16

Factor VIII (%)

50–150

90–210

97–312

143–353

16, 40

Factor IX (%)

50–150

103–172

154–217

164–235

16

Factor XI (%)

50–150

80–127

82–144

65–123

16

Factor XII (%)

50–150

78–124

90–151

129–194

16

Fibrinógeno (mg/100 ml)

233–496